HOME >> BIOLOGY >> NEWS
Mechanism to overcome Gleevec resistance demonstrated

PORTLAND, Ore. Amid the glowing results for chronic myelogenous leukemia (CML) patients using Gleevec the past three years, the one reality check has been that a majority of the patients with advanced disease eventually relapse and die of the leukemia.

An article to be published in the Dec. 15 issue of the journal Cancer Research shows that, in the lab, the molecular mutations that produce a resistance to Gleevec can be overcome. Brian Druker, M.D., Howard Hughes Medical Institute Investigator and JELD-WEN Chair of Leukemia Research at the Oregon Health & Science University Cancer Institute, and colleagues report that a compound called PD180970 successfully stopped the activity of several mutations found in patients who developed a resistance to Gleevec.

"The good news is that it appears possible to develop drugs that can overcome the resistance to Gleevec," said Druker. "Although this particular compound is a long way from clinical trials, we've proved a principle and now need to apply it to other compounds that can be developed into effective drugs."

Druker collaborated with pharmaceutical company Novartis to develop Gleevec into a successful treatment for CML. Last year the Food and Drug Administration approved Gleevec in record time for a cancer therapy. Recent studies have shown Gleevec to be up to 10 times more effective than the previous standard treatment for CML, interferon. However, patients whose disease has advanced to the "blast crisis" stage do not fare as well on Gleevec. While 60 percent of advanced CML patients show initial response to the drug, most of those patients relapse after several months.

"Eventually we hope to tailor a treatment to each individual, so if they are prone to a particular molecular mutation, or resistance to Gleevec, we can combine it with a more specific drug that will help overcome that resistance," said Druker.

Gleevec targets the activity of CML cells while leaving normal cells alon
'"/>

Contact: Martin Munguia
munguiam@ohsu.edu
503-494-4156
Oregon Health & Science University
15-Dec-2002


Page: 1 2

Related biology news :

1. Mechanism controls movement of cell structures
2. Mechanism that enables fetus to survive in mother under study
3. Mechanism believed found that regulates movement within cells
4. Mechanism for generating autoimmunity-suppressing cells identified
5. Mechanism found that appears to keep body tissues together
6. Discovery Of Mechanism Causing Colon Cancer
7. Researchers Discover Mechanism Of Cleft Palate Development
8. The Origins Of Hereditary Breast Cancer -- Studies With Knock-Out Mice Reveal Underlying Mechanisms
9. Researchers Identify Mechanism That May Regulate Protein Involved In Sex Differentiation, Stress, Hunger
10. Reversible Process For Forming Supramolecular Polymers Could Be The Basis Of Fibers, Molecular Transport Mechanisms
11. Mechanism For Fungal Adherence Found, Possible Key To Disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: